Hans-Reiner Figulla

Founder at JenaValve Technology, Inc.

Hans-Reiner Figulla

Hans-Reiner Figulla

Founder at JenaValve Technology, Inc.

Overview
Career Highlights

JenaValve Technology, Inc.
PubMed
JenaValve Technology GmbH

RelSci Relationships

197

Number of Boards

2

Birthday

07/1949

Age

71

Relationships
RelSci Relationships are individuals Hans-Reiner Figulla likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at JenaValve Technology, Inc.

Relationship likelihood: Strong

Senior Advisor at INKEF Capital BV

Relationship likelihood: Strong

Partner, Life Sciences at Andera Partners SCA

Relationship likelihood: Strong

Founder at Neomed Management AS

Relationship likelihood: Strong

Executive Vice President-Life Sciences at Gimv NV

Relationship likelihood: Strong

Founder & Chief Executive Officer at Valiance Advisors LLP

Relationship likelihood: Strong

Former Chief Executive Officer, Founder at Axonics Modulation Technologies, Inc.

Relationship likelihood: Strong

Managing Partner, Healthcare at VI Partners AG

Relationship likelihood: Strong

Partner at Neomed Management AS

Relationship likelihood: Strong

Managing Director at Eagle NV

Relationship likelihood: Strong

Paths to Hans-Reiner Figulla
Potential Connections via
Relationship Science
You
Hans-Reiner Figulla
Founder at JenaValve Technology, Inc.
Career History
Founder
Current

JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE.

Co-Founder
Tenure Unconfirmed
Co-Founder
2006 - Prior

JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany.

Boards & Committees
Member, Board of Directors
Current

JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany.

Investments
Details Hidden

JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Hans-Reiner Figulla. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Hans-Reiner Figulla's profile does not indicate a business or promotional relationship of any kind between RelSci and Hans-Reiner Figulla.